Table 5.
Training initiatives* provided at EU level by public-private partners of EUnetHTA.
| Promoter | Training initiatives title | Year of delivery | Type of training initiative | Target | Topic | Technology addressed in the course |
|---|---|---|---|---|---|---|
| ISPOR— International Society for Pharmacoeconomics and Outcomes Research |
Health technology assessment training program (27) | 2015; 2016; 2017; 2018; 2019; 2020 | In attendance course | Users and doers in government - Public and private payers industry, health plans, academia - Patient group representatives |
Economic evaluation (budget impact analysis; cost evaluation) | Health technology |
| Modeling health care costs- part I characteristics of health care costs (44) | 2020 | Virtual training | Healthcare stakeholders | Economic evaluation (budget impact analysis; cost evaluation) | Health technology | |
| Modeling health care costs—Part II: methods and guidelines for estimating health care costs (45) | 2020 | Virtual training | Healthcare stakeholders | Economic evaluation (cost-effectiveness analysis; cost-utility analysis) | Health technology | |
| Modeling health care costs—part III: estimation from censored data (46) | 2020 | Virtual training | Healthcare stakeholders | Economic evaluation (methodology; budget impact analysis) | Health technology | |
| Markov model toolkit: concepts, assumptions and examples (47) | 2020 | Virtual training | Healthcare stakeholders | Economic evaluation (Markov modelling) | Health technology | |
| Introduction to pharmaco-economics (48) | 2020 | Virtual training | Healthcare stakeholders | Economic evaluation (cost-effectiveness analyses) | Drugs | |
| Cost-of-illness/cost-estimation (COI/CE) (49) | 2020 | Virtual training | Healthcare stakeholders | Economic evaluation (cost-of-illness/cost-estimation) | Health technology | |
| Cost-minimization/cost-consequence (CMA/CCA) (50) | 2020 | Virtual training | Healthcare stakeholders | Economic evaluation (cost-of-illness /cost-estimation) | Health technology | |
| Introduction to budget impact analysis (BIA) - part I (51) | 2020 | Virtual training | Healthcare stakeholders | Economic evaluation (budget impact analysis) | Health technology | |
| Introduction to budget impact analysis (BIA) - part II (52) | 2020 | Virtual training | Healthcare stakeholders | Economic evaluation (budget impact analysis) | Health technology | |
| Cost-effectiveness analysis (CEA) and cost-utility analysis (CUA) (53) | 2020 | Virtual training | Healthcare stakeholders | Economic evaluation (cost-effectiveness analysis and cost-utility analysis) | Health technology | |
| Patient reported outcomes: analysis and interpretation (54) | 2020 | Virtual training | Healthcare stakeholders | Patients reported outcomes | Health technology | |
| Patient reported outcomes: instrument development (55) | 2020 | Virtual training | Healthcare providers | Patients reported outcomes | Health technology | |
| EUnetHTA JA2 | HTA core model training course (56) | 2015 | In-attendance Training Course | HTA Agencies | HTA methodology (HTA core model) and application | Health technology |
| Overview of HTA core model training materials (57) | 2016 | b-learning course | EUnetHTA members Agencies | HTA methodology (HTA core model) and application | Health technology | |
| Key principles of HTA or what is meant for HTA (58) | 2014 | Training Course | EUnetHTA stakeholders | HTA methodology and application | Health technology | |
| IMI—Innovative Medicines Initiative | Real-world evidence in medicine development, - getreal (59) | 2020 | Virtual course | Pharmaceutical companies regulatory authorities health technology assessment bodies patients' organizations | HTA methodology and application | Health technology |
*
All courses were in English language.